BULLISHWHALES
BullishWhales · Analysts · Analyst Profile

Salveen Richter

Goldman Sachs · Equity Research Analyst

Analyst rating accuracy & track record

Salveen Richter does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
FDMT4D Molecular Therapeutics Inc
Buy$44.00May 2025+217.9%Miss
ADPTAdaptive Biotechnologies Corp
Buy$10.00May 2025+37.9%Hit
ADPTAdaptive Biotechnologies Corp
Buy$9.00Mar 2025+57.6%Hit
RLAYRelay Therapeutics Inc
Buy$18.00Feb 2025+191.4%Miss
MRNAModerna Inc
Buy$99.00Jan 2025+3.4%Miss
APLSApellis Pharmaceuticals Inc
Buy$36.00Nov 2024−31.0%Miss
MRNAModerna Inc
Buy$139.00Sep 2024−55.0%Miss
RLAYRelay Therapeutics Inc
Buy$20.00Sep 2024−37.6%Miss
FDMT4D Molecular Therapeutics Inc
Buy$81.00Feb 2024−79.5%Miss
LYELLyell Immunopharma Inc
Buy$12.00May 2022−29.6%Miss
CLLSCellectis SA
Sell$2.00May 2022+50.4%Hit
CLLSCellectis SA
Sell$11.00Mar 2020−26.4%Hit
Go to

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30